SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Lifecore Biomedical, Inc.
FARMINGTON — “Ms. Voss!” a student exclaimed, proudly holding a syringe full of fake blood that’s a shade or two lighter than the real item. The spontaneous celebration of success was part of a lab ...
Psyence Biomedical (PBM) announced a major clinical milestone with multiple patients successfully dosed in its ongoing Phase IIb clinical trial ...
SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Lifecore Biomedical class action lawsuit seeks to represent purchasers or acquirers of Lifecore ...
Sponsored by LSU’s Pennington Biomedical Research Center For many living with diabetes or many other endocrine related conditions, access to cutting edge treatment remains fragmented. LSU’s Pennington ...
A new lab space and certified nursing assistant program opened with the new school year at McHenry Community High School, and teachers hope it will help students build strong foundations for any type ...
The idea that they could train to be public health research scientists in 11th grade never occurred to Redwood High School juniors Scout Wellmeier and Sebastian Solomon — until now. “I never really ...
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lifecore Biomedical, Inc. (NASDAQ: LFCR) securities between October 7, 2020 and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results